作者:
Aliakbar Khalili,Yazdi [1]
;
Sumera,Perveen [1]
;
Cheng,Dong [1]
;
Xiaosheng,Song [1]
;
Aiping,Dong [1]
;
Magdalena M,Szewczyk [1]
;
Matthew F,Calabrese [2]
;
Agustin,Casimiro-Garcia [3]
;
Subramanyam,Chakrapani [2]
;
Matthew S,Dowling [2]
;
Emel,Ficici [2]
;
Jisun,Lee [2]
;
Justin I,Montgomery [2]
;
Thomas N,O'Connell [2]
;
Grzegorz J,Skrzypek [2]
;
Tuan P,Tran [2]
;
Matthew D,Troutman [2]
;
Feng,Wang [2]
;
Jennifer A,Young [2]
;
Jinrong,Min [1]
;
Dalia,Barsyte-Lovejoy [1]
;
Peter J,Brown [4]
;
Vijayaratnam,Santhakumar [1]
;
Cheryl H,Arrowsmith [1]
;
Masoud,Vedadi [1]
;
Dafydd R,Owen [4]
作者单位:
Structural Genomics Consortium, University of Toronto Toronto ON Canada.
[1]
Pfizer Research & Development Groton CT USA.
[2]
Pfizer Research & Development Cambridge MA USA dafydd.owen@pfizer.com.
[3]
Department of Pharmacology and Toxicology, University of Toronto Toronto ON Canada.
[4]
Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto Toronto ON Canada.
[5]
DOI
10.1039/d3md00633f
PMID
38516600
发布时间
2024-03-23